Pre-clinical pharmacokinetics of UK-453,061, a novel non-nucleoside reverse transcriptase inhibitor (NNRTI), and use of in silico physiologically based prediction tools to predict the oral pharmacokinetics of UK-453,061 in man

G. Allan Clinical Pharmacology, Pharmacokinetics, Dynamics and Metabolism , Sandwich, UK

J. Davis Clinical Pharmacology, Pharmacokinetics, Dynamics and Metabolism , Sandwich, UK

M. Dickins Clinical Pharmacology, Pharmacokinetics, Dynamics and Metabolism , Sandwich, UK

I. Gardner Clinical Pharmacology, Pharmacokinetics, Dynamics and Metabolism , Sandwich, UK

T. Jenkins Clinical Research, Pfizer Global Research and Development , Sandwich, UK

H. Jones Clinical Pharmacology, Pharmacokinetics, Dynamics and Metabolism , Sandwich, UK

R. Webster Clinical Pharmacology, Pharmacokinetics, Dynamics and Metabolism , Sandwich, UK

H. Westgate Clinical Pharmacology, Pharmacokinetics, Dynamics and Metabolism , Sandwich, UK

Your download is now in progress and you may close this window